ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Antonia, SJ; Gettinger, SN; Goldman, J; Brahmer, J; Borghaei, H; Chow, LQ; Ready, NE; Gerber, DE; Juergens, R; Shepherd, F; Laurie, SA; Young, T; Geese, WJ; Agrawal, S; Li, X; Hellmann, MD

Published Date

  • November 2016

Published In

Volume / Issue

  • 11 / 11S

Start / End Page

  • S250 - S251

PubMed ID

  • 27969442

Pubmed Central ID

  • 27969442

Electronic International Standard Serial Number (EISSN)

  • 1556-1380

Digital Object Identifier (DOI)

  • 10.1016/j.jtho.2016.09.008

Language

  • eng

Conference Location

  • United States